Recall: D-0579-2023
Class II - Potentially Harmful
Class IIClassification
2023-05-09Initiated
TerminatedStatus
B. Braun Medical IncFirm
Product
Heparin Sodium, 25,000 USP units per 250mL, (100 USP units per mL) in 5% Dextrose injection, 250 ml Excel Container, B. Braun Medical Inc. Bethlehem, PA 18018, USA; API from Spain NDC: 0264-9587-20,
Reason
Subpotent: Low anti-factor IIa Potency.
Distribution
Nationwide in the USA
Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.